Docket Management
Docket: 95N-0304 - Dietary Supplements Containing Ephedrine Alkaloids
Comment Number: EC -796

Accepted - Volume 322

Comment Record
Commentor Dr. June Wiles Date/Time 2003-03-27 06:54:30
Organization Bio-Ion Institute
Category Dietary Supplement Industry

Comments for FDA General
1. General Comments FDA already has all the enforcement powers it needs in regards to Ephedra. DSHEA as it currently stands has been adequate and appropriate for almost 10 years and should not be changed, as changing it would place an undue hardship on the American people who seek innovative and safe supplements.

EC -796